Get the Stockscreener App
2.19
2.67%
-0.06
After Hours:
2.28
0.09
+4.11%
Lipella Pharmaceuticals Inc stock is traded at $2.19, with a volume of 43,251.
It is down -2.67% in the last 24 hours and down -45.52% over the past month.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
See More
Previous Close:
$2.25
Open:
$2.25
24h Volume:
43,251
Relative Volume:
0.02
Market Cap:
$2.65M
Revenue:
-
Net Income/Loss:
$-4.74M
P/E Ratio:
-2.92
EPS:
-0.75
Net Cash Flow:
$-3.46M
1W Performance:
-14.12%
1M Performance:
-45.52%
6M Performance:
-32.24%
1Y Performance:
-63.13%
1-Day Range:
$2.1606
$2.30
1-Week Range:
$2.0202
$2.50
52-Week Range:
$2.0202
$12.00
Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile
Name
Lipella Pharmaceuticals Inc
Sector
Industry
Phone
412-901-0315
Address
400 N LEXINGTON ST, PITTSBURGH
Compare LIPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIPO
Lipella Pharmaceuticals Inc
|
2.19 | 2.65M | 0 | -4.74M | -3.46M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Lipella Pharmaceuticals Inc Stock (LIPO) Latest News
Spartan Capital Securities, LLC Proudly Serves as the Sole Agent in Lipella Pharmaceuticals Inc. - Ukraine Business Journal
Spartan Capital Securities, LLC Announces Key February Transactions - The Manila Times
Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewswire Inc.
Lipella Pharmaceuticals stock hits 52-week low at $2.21 - Investing.com India
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $3,788,000 Private Placement - The Manila Times
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement - Yahoo Finance
Lipella Pharmaceuticals (LIPO) Expected to Announce Earnings on Tuesday - Defense World
FDA approves Lipella's oral treatment access program - MSN
Lipella Pharmaceuticals modifies agreement with Spartan Capital By Investing.com - Investing.com South Africa
Lipella Pharmaceuticals modifies agreement with Spartan Capital - Investing.com
With New Data, Lipella Plots 2025 Milestones For Oral Rinse Tacrolimus - News & Insights
Analyzing Lipella Pharmaceuticals (NASDAQ:LIPO) and IDEAYA Biosciences (NASDAQ:IDYA) - Defense World
Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310 - TipRanks
3 Penny Stocks to Watch Now, 2/13/25 - TipRanks
Lipella Pharmaceuticals Announces Positive Phase 2a Results for LP-310 in Oral Lichen Planus Treatment - Defense World
Biotech Rips On Topline Analysis - The Globe and Mail
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes - AOL
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus - GlobeNewswire
Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment - Marketscreener.com
Stock market news: Firefly Neuroscience +214.56%, Dominari Holdings +37.66% among top gainers during midday trading - Business Upturn
Stock market today: Firefly Neuroscience +60.32%, Dominari Holdings +36.36% among top gainers in early trading - Business Upturn
Lipella Pharmaceuticals Gains FDA Approval for LP-310 - TipRanks
Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session - Stocks Telegraph
Clinical Trials News Live Feed - StockTitan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
How Did Markets React to the Latest Round of Tariff Announcements? - The Globe and Mail
Clinical Trial Success: Lipella's LP-310 Slashes Pain Scores by 64% in Oral Disease Study - StockTitan
Top Small Cap Stocks To Watch NowFebruary 06th - MarketBeat
Lipella Pharmaceuticals Inc (LIPO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Taking on analysts’ expectations and winning: Lipella Pharmaceuticals Inc (LIPO) - SETE News
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable
Analyzing the Price-to-Earnings Ratio of Lipella Pharmaceuticals Inc (LIPO) - The News Heater
🔬 Latest pharma industry updates 👇 - substack.com
Stock summary: Lipella Pharmaceuticals posted weekly surge of 13.70% as it got FDA approval for an expanded access program - Business Upturn
LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily
Is Lipella Pharmaceuticals Inc (NASDAQ:LIPO) stock a better investment at this time? - US Post News
Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Lipella Pharmaceuticals Inc [LIPO] Revenue clocked in at $0.48 million, up 52.46% YTD: What’s Next? - The DBT News
FDA approves Lipella’s oral treatment access program By Investing.com - Investing.com Nigeria
Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment - Mugglehead
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Offerings News Live Feed - StockTitan
Stock market news: Lipella Pharmaceuticals +96.90%, Digital Turbine +66.19% among top gainers as investors assess corporate earnings report - Business Upturn
Stock market news: Lottery.com surged by 93.55% while Lipella Pharmaceuticals posted rise of 86.44% during mid day trading - Business Upturn
Strong Earnings Drive Digital Turbine (APPS) Stock’s Market Rally - Stocks Telegraph
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook - Benzinga
Acquisition Announcement Propels Altus Power (AMPS) Shares Upward - Stocks Telegraph
Stock market today: Lipella Pharmaceuticals jumped by 98.06% whereas ReTo Eco-Solutions plunged by 38.75% in early trading - Business Upturn
Lipella Pharmaceuticals Inc Stock (LIPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):